Fund Holdings — ARCH Venture Management, LLC

Total Portfolio Value:
$163.51M
Total Bought:
$92.74M
Total Sold:
$86.79M
Net Transaction:
+$5.94M
Notable People:
Robert Taylor Nelsen
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)03,233,490+3,233,490$0$92.74M56.72%+$92.74M
Verve Therapeutics, Inc.2,008,8092,008,8090$26.64M$28.00M17.13%+$1.37M
Erasca, Inc.(ERAS)11,055,55411,055,5540$21.78M$23.55M14.40%+$1.77M
Denali Therapeutics Inc.(DNLI)693,749381,249-312,500$14.31M$8.18M5.00%-$6.13M
Gossamer Bio, Inc.(GOSS)8,055,9168,055,9160$6.71M$7.35M4.50%+$642.1K
Unity Biotechnology, Inc.1,004,8171,004,8170$2.41M$1.94M1.19%-$472.3K
Singular Genomics Systems, Inc.3,798,9263,798,9260$1.45M$1.75M1.07%+$300.5K
EQRX, INC.COM36,335,3750-36,335,375$80.66M$0—-$80.66M
Page 1 of 1
ARCH Venture Management, LLC — 13F Holdings — Q4 2023 | TickerTrail